CHA
AGN

Cedar Hill Associates’s Allergan plc AGN Stock Holding History

Cedar Hill Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$908K Sell
6,800
-22,512
-77% -$3.69M 0.35% 61
2018
Q3 		$5.58M Sell
29,312
-3,240
-10% -$595K 1.25% 33
2018
Q2 		$5.43M Sell
32,552
-4,050
-11% -$650K 1.13% 36
2018
Q1 		$6.16M Sell
36,602
-4,115
-10% -$690K 1.22% 35
2017
Q4 		$6.66M Sell
40,717
-2,119
-5% -$380K 1.16% 40
2017
Q3 		$8.78M Sell
42,836
-1,810
-4% -$421K 1.52% 27
2017
Q2 		$10.9M Sell
44,646
-1,920
-4% -$451K 2.26% 17
2017
Q1 		$11.1M Sell
46,566
-16,745
-26% -$3.9M 2.32% 19
2016
Q4 		$13.3M Buy
63,311
+9,941
+19% +$2.06M 2.23% 21
2016
Q3 		$12.3M Buy
53,370
+17,182
+47% +$4.2M 2.01% 24
2016
Q2 		$8.36M Buy
+36,188
New +$8.34M 1.44% 36

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Cedar Hill Associates's AGN Position: Q4 2018 in Review

Cedar Hill Associates reduced its Allergan plc (AGN) stake by 77% in Q4 2018, selling an estimated $3.69M and leaving 6,800 shares worth $908K. The position accounts for 0.35% of the portfolio, ranked #61.

Cedar Hill Associates first reported a position in AGN in Q2 2016 and has held it in 11 quarters since. The position peaked at $13.3M in Q4 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Cedar Hill Associates held 6,800 shares of Allergan plc worth $908K as of Q4 2018.
  • Cedar Hill Associates sold 22,512 Allergan plc shares in Q4 2018, an estimated $3.69M.
  • Allergan plc made up 0.35% of Cedar Hill Associates's portfolio in Q4 2018, its #61 holding.
  • Cedar Hill Associates first reported a position in Allergan plc in Q2 2016 and has held it in 11 quarters since.
  • Cedar Hill Associates's Allergan plc position peaked at $13.3M in Q4 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Cedar Hill Associates's 13F filing for Q4 2018, filed 13 Feb 2019.